Emmaus Life Sciences, Inc. (EMMA) stock
EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
$0.05−0.01 (-14.38%)
Close on Oct 19, 2026Market cap $6.03MP/E –Yield –
Earnings
Emmaus Life Sciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Nov 13, 2026
Q3 FY2026 · estimated, during market hours
Revenue, Q2 FY2026
$6.30M
+125.0% on a year earlier
EPS, Q2 FY2026
$0.02
-$0.02 a year earlier
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Emmaus Life Sciences's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q3 FY2026ended Sep 30, 2026 | Nov 13, 2026Expected | – | – | – | – |
| Q2 FY2026ended Jun 30, 2026 | Aug 14, 2026during market hours | $6.30M | +125.0% | $0.02 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 15, 2026during market hours | $2.00M | – | -$0.05 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 31, 2026before the open | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 14, 2025during market hours | $3.40M | -38.2% | -$0.03 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 14, 2025during market hours | $2.80M | – | -$0.02 | Release |
| Q4 FY2024ended Dec 31, 2024 | Apr 14, 2025during market hours | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 19, 2024during market hours | $5.50M | – | $0.03 | Release |
| Q2 FY2024ended Jun 30, 2024 | Sep 10, 2024during market hours | – | – | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 14, 2023before the open | – | – | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 14, 2023during market hours | – | – | – | Release |
| Q1 FY2023ended Mar 31, 2023 | May 15, 2023before the open | – | – | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 31, 2023during market hours | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 15, 2022during market hours | – | – | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 15, 2022during market hours | – | – | – | Release |
| Q1 FY2022ended Mar 31, 2022 | May 13, 2022before the open | – | – | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 31, 2022during market hours | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Emmaus Life Sciences has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Emmaus Life Sciences puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Emmaus Life Sciences filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- News
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?